About us

Company Overview

IDS was established in 1968 and is one of the leading pharmaceutical and consumer healthcare product distributors in the region.

Our mission is to build partnerships of shared success and relationships of mutual appreciation with a collaborative network of pharmaceutical suppliers within the region, while keeping the customer’s interests first. We connect organisations and people through timely deliveries, full network coverage, competitive pricing and customised solutions to meet the distribution and support needs of manufacturers and healthcare providers.

During the last ten years, IDS has shown pronounced growth in every category including growing yearly revenues, market share, number of prescriptions, product portfolio, and representing international partners. Our product portfolio falls under different Therapeutic Classes, such as, Antibacterial, Asthma, Hypertension, Diabetes, Cardiovascular, Muscle Relaxant, Anticoagulant, Anti-rheumatic, Erectile Dysfunction and other classes.

More than 90% of our launches are successful and our partners’ sales and presence are growing year over year.

With a turnover exceeding AED 300 million in 2015, the distribution side of the business is going from strength to strength, with a minimum annual growth of 15% and a progressive annual sales growth in our consumer portfolio of 25% over the past 4 years.

IDS is in a strong financial position, and the double-digit growth witnessed over the last decade is expected to continue well into the future.

Our long-term strategy is the launch of Pharmax, a state-of-the-art manufacturing facility used as primary packaging, secondary re-packaging and manufacturing from API. The custom built facility will produce high quality affordable healthcare and pharmaceutical products essential to a healthier and happier lifestyle.

words from our Group CEO

Pushing our limits to provide the best possible service in the UAE.

Our mission is to become a leading regional healthcare & pharmaceutical supplier and distributor by aggressively growing our revenue base at no less than 20% per annum through vertical diversification and expansion of our healthcare and pharmaceutical product portfolio.

Our vision focuses on the aim to help people improve the health and quality of their life by delivering a wide range of affordable healthcare and pharmaceutical products, and by continuously searching, developing and producing products essential to a healthier & happier lifestyle.

GROUP CEO

Ahmad Tabari

aht_ceo_image